Does Merkel Have a Plan B?

{
  "authors": [
    "Judy Dempsey"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace",
    "Carnegie Europe"
  ],
  "collections": [],
  "englishNewsletterAll": "ctw",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Europe",
  "programAffiliation": "EP",
  "programs": [
    "Europe"
  ],
  "projects": [],
  "regions": [
    "Europe",
    "Western Europe",
    "Germany",
    "Iran"
  ],
  "topics": [
    "EU",
    "Migration"
  ]
}

In The Media

Carnegie Europe

Does Merkel Have a Plan B?

The German chancellor’s open-door policy toward the refugees is a challenge to her leadership. As public debate gets harsher in Germany, will Angela Merkel opt for a plan B?

By Judy Dempsey

Published on Jan 21, 2016

Source: Deutsche Welle

Speaking on Deutsche Welle’s Quadriga, Judy Dempsey discussed if Angel Merkel can survive one of the biggest test of her career: the refugee crisis. She was joined by Alan Posener, journalist at Die Welt, and Erik Kirschbaum, Germany correspondent at Los Angeles Times.

This broadcast was originally aired on Deutsche Welle.

About the Author

Judy Dempsey

Nonresident Senior Fellow, Carnegie Europe

Dempsey is a nonresident senior fellow at Carnegie Europe

Recent Work

Commentary
Europe Needs to Hear What America is Saying
- Judy Dempsey
Commentary
Babiš’s Victory in Czechia Is Not a Turning Point for European Populists
- Judy Dempsey

EU Migration Europe Western Europe Germany Iran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

Article
Can Geopolitical Alignment Seal the India-EU FTA?
This article argues that the geopolitical circumstances have never been more conducive, not merely for the early conclusion of the free trade agreement (FTA) between India and the EU, but also for crafting a substantive and comprehensive strategic partnership.
Mohan Kumar
Commentary
How WHO’s “One Health” Program Can Help India Tackle Monkeypox
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
Paper
Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
Commentary
Combating Vaccine Hesitancy in India
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
Commentary
How Should Countries Study Viruses Safely?
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma

More Work from Carnegie India

Article

Can Geopolitical Alignment Seal the India-EU FTA?

This article argues that the geopolitical circumstances have never been more conducive, not merely for the early conclusion of the free trade agreement (FTA) between India and the EU, but also for crafting a substantive and comprehensive strategic partnership.

Mohan Kumar

Commentary

How WHO’s “One Health” Program Can Help India Tackle Monkeypox

With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

Shruti Sharma

Paper

Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

Shruti Sharma

Commentary

Combating Vaccine Hesitancy in India

Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

Shruti Sharma

Commentary

How Should Countries Study Viruses Safely?

The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

Shruti Sharma